# Prediction of Therapeutic Response to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer Patients Using Spatial Transcriptomics

> **NCT06373055** · — · RECRUITING · sponsor: **Yonsei University** · enrollment: 250 (estimated)

## Conditions studied

- Muscle-invasive Bladder Cancer

## Interventions

- **OTHER:** neoadjuvant chemotherapy followed by radical cystectomy

## Key facts

- **NCT ID:** NCT06373055
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2033-11
- **Final completion:** 2033-11
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2024-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06373055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06373055, "Prediction of Therapeutic Response to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer Patients Using Spatial Transcriptomics". Retrieved via AI Analytics 2026-09-14 from https://api.ai-analytics.org/clinical/NCT06373055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*